Cidara Provides Corporate Update and Reports Fourth Quarter and Full Year 2016 Financial Results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. SPCX
2. ABBV
3. SPY
4. MU
5. META
6. FDX
7. IBM
8. PRIM
9. ACN
10. USO

Go back to Cidara Provides Corporate Update and Reports Fourth Quarter and Full Year 2016 Financial Results

Cidara Therapeutics (CDTX) Reports Q4 Loss of $0.88/Share

March 15, 2017 5:25 PM EDT

Cidara Therapeutics (NASDAQ: CDTX) reported Q4 EPS of ($0.88), versus ($0.72) reported last year. Revenue for the quarter came in at $0 , versus $0 reported last year.

For earnings history and earnings-related data on Cidara Therapeutics (CDTX) click here.

... More